Board
The Board comprises 9 members, including 3 independents, 5 representatives of AXA Private Equity, DIANA's majority shareholder since 2007, and a representative of Cognetas.
|
|
Yves Boisdron, President of the Board, Independent member
After his studies at ENSIC and a Master's Degree from the University of Texas, Yves Boisdron began his career as engineer at Process Badger Co and then served as General Manager of Gist Brocades from 1974 to 1981. From 1981 to 1998, he occupied various management positions at Rhône-Poulenc (Brazil and US). He joined Rhodia in 1998 as President of the Asia Pacific Zone and then served as Executive Vice President of Strategy from 2003 to 2007.
|
"DIANA is a great team of dynamic entrepreneurs developing a worldwide leadership in its businesses. Innovation for the well-being of human and animals is the primary mission of the company. The social and environmental responsibility drives every member of DIANA. It is an honor and a pleasure to chair the Board of a winning company!"
|
|
Thomas Derville, Independent member
Graduate of HEC, Thomas Derville began his career at Danone, where he was appointed CEO of Danone Italiana in 1987. He then served as CEO of Amora, CEO of Liebig-Maille-Amora and, in 1998, as Chairman of Amora-Maille, the European sauces and condiments leader. In 2004, he was appointed Senior Vice President Health and Wellness of Unilever. After his retirement from Unilever in 2005, Thomas Derville has been Chairman of the competitive cluster Taste-Nutrition-Health Vitagora until 2006. He is member of the Board of DIANA since 2005.
|
“I was fortunate to support DIANA since 2005, at the Board level, first as President and then as a member, after the disposal of Cognetas to AXA Private Equity. This company has been a constant source of admiration and inspiration to me : by its ambition (becoming a world leader in its areas); by the magnitude of its vision (being a global solutions provider all over the world); by its dynamism (speed to adapt its structures in research, industry and customer service); by its inventiveness (ability to innovate as a “pioneer”, proven for instance by the new activity Aquativ) and by its performances (an impressive track record in terms of growth and profitability). DIANA implements a clearly articulated project, which acts as a source of energy and enthusiasm for its teams and involves the pursuit of excellence at all levels. To me, DIANA is an example of what LBO can better promote in terms of growth and competitiveness. Personally, I am more than happy to take part, at my modest level, to the implementation of this magnificent project.”
|
|
Olivier Jacquesson, Independent member
At the end of his studies in engineering and management, Olivier Jacquesson joined the pharmaceutical industry at Roussel-Uclaf, where he managed several operational and international divisions. Appointed Head of Roussel-Uclaf in 1994, he took part to the Group’s development and globalisation, ensuring the mergers with Hoescht, Marion, Rhône-Poulenc Pharma and Sanofi-Aventis. After his retirement from Sanofi-Aventis in 2007, Olivier Jacquesson contributed to companies in the areas of Health (Merial, Keocity) and Nutrition. He joined DIANA’s Board in 2007.
|
|
|
Philippe Poletti, AXA Private Equity
After his studies at ESLSCA (specialising in Finance) and INSEAD, Philippe Poletti began his career in consulting in 1990 at Solving International in Paris and Milan. He spent 3 years at Desnoyers (copper tube manufacturer) as Business Development Manager and Deputy Director General and worked as Mergers Acquisitions & Divestitures Manager at DMC (textile group) from 1997 to 1999. Philippe Poletti joined AXA Private Equity in 1999 and is now Senior Managing Director in Paris. He is member of the Boards of DIANA, Unipex and Go Voyages.
|
|
|
Bruno Ladrière, AXA Private Equity
Bruno Ladrière holds a PhD in Medicine and a MBA in Finance from the Wharton School (USA). He has worked in strategy consulting for Corporate Decisions Inc. and in the pharmaceutical industry for Rhône-Poulenc. He was a co-founding partner of Triago from 1994 to 1997 and then spent 5 years working as Investment Manager at PAI. Bruno Ladrière joined AXA Private Equity in 2002 and is now Managing Director. He is member of the Boards of DIANA, TLD and Aixam Mega.
|
|
|
Lise Fauconnier, AXA Private Equity
Graduate of HEC, Lise Fauconnier began her career at Clinvest, with responsibility for Mergers & Acquisitions, restructuring and portfolio management. She was appointed Investment Manager at EURIS. Lise Fauconnier joined AXA Private Equity in 1998 and is Managing Director Paris. She is member of the Boards of DIANA, Go Voyages, Newrest and Linedata Services.
|
|
|
Thibault Basquin, AXA Private Equity
At the end of his studies at ESCP (major in Finance), Thibault Basquin began his career at Arthur Andersen in 2000 as an Auditor. He joined AXA Private Equity in 2001. He is member of the Boards of DIANA and Novacap and also Board member of the AXA Private Equity Foundation.
|
|
|
Daniel Setton, AXA Private Equity
Graduate from HEC and holding a MASS diploma from Paris Sorbonne, Daniel Setton joined AXA Private Equity in 2007. He previously carried out his internships within the AXA Private Equity department of Co-Investment and at the New York office. Daniel Setton is a member of the Boards of DIANA, Newrest, Odigeo and Photonis.
|
|
|
Patrick Eisenchteter, Motion Equity Partners
Graduate of Lyon Business School, Patrick Eisenchteter spent six years at Andersen in Paris and New-York. He joined Cognetas in 2001, having previously been a Vice President of Europe@Web and an Investment Director at Fonds Partenaires (Lazard Frères & Cie).
|
